Proqr Therapeutics NV

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Proqr Therapeutics NV
TickerPRQR
CIK #0001612940
CUSIPN71542109
SectorLife Sciences - Pharmaceutical Preparations
AddressDarwinweg 24, Leiden, 2333CR
Source [EDGAR]
CIK Filing 2011 - 2026
[0001612940] 3
[0001612940] 4
[0001612940] 6-K
[0001612940] SC 13D
[0001612940] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Privium Fund Management BV Proqr Therapeutics NV [2026-01-20] 0.0
van Herk Investments BV Proqr Therapeutics NV [2025-05-28] 0.0
Adage Capital Management LP Proqr Therapeutics NV [2025-02-12] 0.0
van Herk Investments BV Proqr Therapeutics NV [2023-09-14] 5.3
FMR LLC Proqr Therapeutics NV [2022-02-09] 0.0
Eli Lilly & Co Proqr Therapeutics NV [2021-09-10] 5.6
Wellington Management Group LLP Proqr Therapeutics NV [2019-11-08] 10.78
Inspirational Visions BV Proqr Therapeutics NV [2019-08-28] 5.1
RTW Investments LP Proqr Therapeutics NV [2019-02-22] 0.22
UBS Group AG Proqr Therapeutics NV [2019-02-15] 5.39
Goldman Sachs Group Inc Proqr Therapeutics NV [2019-02-07] 8.8
RTW Investments LP Proqr Therapeutics NV [2018-09-17] 5.05
Adage Capital Partners GP LLC Proqr Therapeutics NV [2018-05-25] 5.88
Aescap Medical Investments BV Proqr Therapeutics NV [2018-04-12] 5.6
Invus Public Equities LP Proqr Therapeutics NV [2018-02-09] 5.96
JDG BV Proqr Therapeutics NV [2017-10-11] 10.5
Invus Public Equities LP Proqr Therapeutics NV [2017-07-06] 6.0
Redmile Group LLC Proqr Therapeutics NV [2017-02-14] 6.76
Prudential Financial Inc Proqr Therapeutics NV [2016-04-11] 11.5
Jennison Associates LLC Proqr Therapeutics NV [2016-04-08] 11.5
Sofinnova Partners SAS Proqr Therapeutics NV [2015-02-17] 12.3
OrbiMed Advisors LLC Proqr Therapeutics NV [2015-02-17] 3.75
FMR LLC Proqr Therapeutics NV [2015-02-13] 0.0
Form 3/4/5 Filer 2011 - 2026
de Boer Daniel Anton
ProQR Therapeutics NV
Filius Bart
Hinsch Gylvin Lykke
Heggie Theresa
Hom Dennis
Lawton Alison Frances
Shannon James Samuel
Platenburg Gerardus Johannes
Valerio Domenico
Maier Martin Alexander
Carreno-Gomez Begona
13F Ownership Over TimeHoldersShares Held
2026-03-31 69 35,100,377
2025-12-31 66 37,203,969
2025-09-30 64 37,543,301
2025-06-30 64 40,589,812
2025-03-31 67 41,327,180
2024-12-31 78 44,478,583
2024-09-30 48 17,503,469
2024-06-30 49 17,326,076
2024-03-31 50 17,588,670
2023-12-31 48 18,532,197
2023-09-30 47 18,716,484
2023-06-30 53 21,289,389
Form 13F Holdings
Firm Period DFND Voting Shares
Franklin Street Advisors Inc /NC [2026-06-30] DFND 150,000 150,000
RFG Advisory LLC [2026-06-30] SOLE 0 64,000
Moody Lynn Lieberson & Walker LLC [2026-06-30] SOLE 25,000 25,000
Farther Finance Advisors LLC [2026-06-30] SOLE 0 1,000
PFS Partners LLC [2026-06-30] SOLE 0 1,000
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com